276 related articles for article (PubMed ID: 31306972)
1. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
Hou Q; Zhu S; Zhang C; Huang Y; Guo Y; Li P; Chen X; Wen Y; Han Q; Liu F
Biomed Pharmacother; 2019 Oct; 118():109206. PubMed ID: 31306972
[TBL] [Abstract][Full Text] [Related]
2. Herbs-partitioned moxibustion improves intestinal epithelial tight junctions by upregulating A20 expression in a mouse model of Crohn's disease.
Shi Y; Guo Y; Zhou J; Wu L; Chen L; Sun Y; Li T; Zhao J; Bao C; Wu H
Biomed Pharmacother; 2019 Oct; 118():109149. PubMed ID: 31302421
[TBL] [Abstract][Full Text] [Related]
3. Herbs-partitioned moxibustion alleviates aberrant intestinal epithelial cell apoptosis by upregulating A20 expression in a mouse model of Crohn's disease.
Zhou J; Wu LY; Chen L; Guo YJ; Sun Y; Li T; Zhao JM; Bao CH; Wu HG; Shi Y
World J Gastroenterol; 2019 May; 25(17):2071-2085. PubMed ID: 31114134
[TBL] [Abstract][Full Text] [Related]
4. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
Cao M; Wang P; Sun C; He W; Wang F
PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
[TBL] [Abstract][Full Text] [Related]
6. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
[TBL] [Abstract][Full Text] [Related]
7. Potential Regulatory Effects of Corticotropin-Releasing Factor on Tight Junction-Related Intestinal Epithelial Permeability are Partially Mediated by CK8 Upregulation.
Yue H; Bin L; Chaoying C; Meng Z; Meng L; Xi W
Cell Physiol Biochem; 2017; 44(3):1161-1173. PubMed ID: 29179184
[TBL] [Abstract][Full Text] [Related]
8. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
[TBL] [Abstract][Full Text] [Related]
9. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
[TBL] [Abstract][Full Text] [Related]
10. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
[TBL] [Abstract][Full Text] [Related]
11. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
Ye X; Sun M
Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
[TBL] [Abstract][Full Text] [Related]
12. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway.
Ji S; Zhang Q
Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
[TBL] [Abstract][Full Text] [Related]
14. Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.
Wu RL; Vazquez-Roque MI; Carlson P; Burton D; Grover M; Camilleri M; Turner JR
Lab Invest; 2017 Jan; 97(1):14-23. PubMed ID: 27869798
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29b-3p promotes intestinal permeability in IBS-D via targeting TRAF3 to regulate the NF-κB-MLCK signaling pathway.
Wang Y; Ke W; Gan J; Zhu H; Xie X; He G; Liu S; Huang Y; Tang H
PLoS One; 2023; 18(7):e0287597. PubMed ID: 37428806
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-16 inhibits the TLR4/NF-κB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.
Xi M; Zhao P; Li F; Bao H; Ding S; Ji L; Yan J
J Biol Chem; 2022 Nov; 298(11):102461. PubMed ID: 36067883
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
Ye D; Ma I; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
[TBL] [Abstract][Full Text] [Related]
18. Berberine Enhances Intestinal Mucosal Barrier Function by Promoting Vitamin D Receptor Activity.
Huang YQ; Liu JL; Chen GX; Shen DT; Zhu W; Chen XL; Liu FB; Hou QK
Chin J Integr Med; 2024 Feb; 30(2):143-151. PubMed ID: 37046128
[TBL] [Abstract][Full Text] [Related]
19. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways.
Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y
J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-155 alleviates sepsis-induced inflammation and intestinal barrier dysfunction by inactivating NF-κB signaling.
Cao YY; Wang Z; Wang ZH; Jiang XG; Lu WH
Int Immunopharmacol; 2021 Jan; 90():107218. PubMed ID: 33296782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
